Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc is a developmental-stage pharmaceutical company that discovers, develops, and commercializes botanical drugs for patients with inflammatory diseases. Its lead product, Phyto-N, targets therapeutic areas including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc and changed its name to Curanex Pharmaceuticals Inc in November 2023. Founded in 1996, it is headquartered in Jericho, New York.